Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.

Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy. Nat Rev Cardiol (2012) 1.04

Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics (2012) 1.02

Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol (2013) 1.01

Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome. Circ Arrhythm Electrophysiol (2011) 0.87

Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev (2017) 0.85

Long QT syndrome: a Korean single center study. J Korean Med Sci (2013) 0.84

Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation. Front Pharmacol (2013) 0.80

β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1. J Cardiovasc Electrophysiol (2011) 0.79

The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm (2012) 0.78

Inherited Arrhythmias: Of Channels, Currents, and Swimming. Biophys J (2016) 0.75

QT Dynamics During Exercise in Asymptomatic Children with Long QT Syndrome Type 3. Pediatr Cardiol (2016) 0.75

Experience with bisoprolol in long-QT1 and long-QT2 syndrome. J Interv Card Electrophysiol (2016) 0.75

Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks. Heart Vessels (2015) 0.75

Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28

Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26

Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med (2013) 6.40

Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04

Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med (2006) 3.59

Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation (2003) 3.57

Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med (2002) 3.35

Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation (2012) 2.53

Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA (2006) 2.50

Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J (2005) 2.39

AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. J Am Coll Cardiol (2006) 2.38

Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30

Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation (2011) 2.23

Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol (2004) 2.20

Fused whole-heart coronary and myocardial scar imaging using 3-T CMR. Implications for planning of cardiac resynchronization therapy and coronary revascularization. JACC Cardiovasc Imaging (2010) 2.17

Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15

Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail (2012) 2.13

Inaccessibility to quinidine therapy is about to get worse. J Am Coll Cardiol (2013) 2.12

Combined head-up tilt and lower body negative pressure as an experimental model of orthostatic syncope. J Cardiovasc Electrophysiol (2003) 2.10

Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia. J Cardiovasc Electrophysiol (2005) 2.10

Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm (2005) 2.07

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol (2008) 2.03

Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol (2009) 1.98

Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol (2006) 1.97

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol (2009) 1.87

AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation (2006) 1.86

Asymptomatic Wolff-Parkinson-White syndrome: is it time to revisit guidelines? J Am Coll Cardiol (2003) 1.86

Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol (2003) 1.84

Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80

Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm (2008) 1.77

PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm (2012) 1.74

The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J (2004) 1.74

Search for the optimal right ventricular pacing site: design and implementation of three randomized multicenter clinical trials. Pacing Clin Electrophysiol (2009) 1.73

Current of injury predicts acute performance of catheter-delivered active fixation pacing leads. Pacing Clin Electrophysiol (2007) 1.73

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2011) 1.73

A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med (2003) 1.69

Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.67

A novel pacing maneuver to localize focal atrial tachycardia. J Cardiovasc Electrophysiol (2006) 1.64

Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64

Mandatory physician reporting of drivers with cardiac disease: ethical and practical considerations. Can J Cardiol (2004) 1.62

Images in cardiovascular medicine. A sensitive dissection: profound bradycardia complicating carotid dissection. Circulation (2008) 1.60

Congenital and acquired long QT syndromes. Can J Cardiol (2003) 1.59

Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion. Circulation (2005) 1.59

Laser lead extraction: is there a learning curve? Pacing Clin Electrophysiol (2005) 1.59

Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Serv Res (2006) 1.58

Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol (2011) 1.58

Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry. Circ Arrhythm Electrophysiol (2012) 1.56